0001225208-13-013159.txt : 20130523
0001225208-13-013159.hdr.sgml : 20130523
20130523171947
ACCESSION NUMBER: 0001225208-13-013159
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130523
FILED AS OF DATE: 20130523
DATE AS OF CHANGE: 20130523
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Caforio Giovanni
CENTRAL INDEX KEY: 0001533201
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-01136
FILM NUMBER: 13869361
MAIL ADDRESS:
STREET 1: BRISTOL-MYERS SQUIBB COMPANY
STREET 2: ROUTE 206 & PROVINCELINE ROAD
CITY: LAWRENCEVILLE
STATE: NJ
ZIP: 08543
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BRISTOL MYERS SQUIBB CO
CENTRAL INDEX KEY: 0000014272
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 220790350
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 345 PARK AVE
CITY: NEW YORK
STATE: NY
ZIP: 10154
BUSINESS PHONE: 2125464000
MAIL ADDRESS:
STREET 1: 345 PARK AVE
CITY: NEW YORK
STATE: NY
ZIP: 10154
FORMER COMPANY:
FORMER CONFORMED NAME: BRISTOL MYERS CO
DATE OF NAME CHANGE: 19891012
4
1
doc4.xml
X0306
4
2013-05-23
0000014272
BRISTOL MYERS SQUIBB CO
BMY
0001533201
Caforio Giovanni
BRISTOL-MYERS SQUIBB COMPANY
345 PARK AVENUE
NEW YORK
NY
10154
1
Pres., US Pharmaceuticals
Common Stock, $0.10 par value
2013-05-23
4
M
0
21333.0000
25.4500
A
84501.2190
D
Common Stock, $0.10 par value
2013-05-23
4
S
0
26647.0000
46.2900
D
57854.2190
D
Option (right to buy)
25.4500
2013-05-23
4
M
0
21333.0000
0.0000
D
2015-02-28
Common Stock, $0.10 par value
21333.0000
0.0000
D
The reporting person sold 17,913 shares to cover the exercise price and taxes in accordance with broker's procedures for sell-to-cover transactions upon the exercise of the option. The remaining 8,734 shares sold were held by the reporting person for more than a year. The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $46.22 to $46.46, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
Twenty-five percent of the stock option award vested on each of the first, second, third, and fourth anniversaries of the grant date, which was March 1, 2005.
/s/ Robert J. Wollin, attorney-in-fact for Giovanni Caforio
2013-05-23